Cerevance is a Biotech company based in San Francisco, CA. It has raised $204M in total funding. Latest round: Series B.
Cerevance is a Biotech company based in San Francisco, CA. Cerevance has raised $204M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2024. The round record for Cerevance runs through 2024; nothing later has been disclosed. Investors on record include Google Ventures, Bill Gates, Casdin Capital, Lightstone Ventures, Foresite Capital, UPMC Enterprises and 6 others. 12 distinct backers are named across the disclosed rounds.
Every Cerevance figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Francisco at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026